Qualis Innovations, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a QLIS research report →
Companywww.qualisinnovations.com
Qualis Innovations, Inc. focuses on the development, production, and distribution of pain management and other central nervous system (CNS) based solutions. Its lead product is SOLACE, a non-invasive medical device to use electromagnetic induction to generate deep heat below the surface of the skin to reduce and relieve pain.
- CEO
- Patrick S. Adams CFA
- IPO
- 2007
- HQ
- Chadds Ford, PA, US
Price Chart
Valuation
- Market Cap
- $5.45M
- P/E
- -324.21
- P/S
- 36.36
- P/B
- 37.57
- EV/EBITDA
- -303.57
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 100.00%
- Op Margin
- -7.99%
- Net Margin
- -11.14%
- ROE
- -14.98%
- ROIC
- -5.45%
Growth & Income
- Revenue
- $221.76K · 0.00%
- Net Income
- $-492,748 · -390.37%
- EPS
- $-0.02 · -300.00%
- Op Income
- $-501,079
- FCF YoY
- -193.37%
Performance & Tape
- 52W High
- $0.94
- 52W Low
- $0.26
- 50D MA
- $0.27
- 200D MA
- $0.28
- Beta
- -2.76
- Avg Volume
- 33
Get TickerSpark's AI analysis on QLIS
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our QLIS Coverage
We haven't published any research on QLIS yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate QLIS Report →